Constellium SE (NYSE:CSTM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Constellium SE (NYSE:CSTM) has received an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $35.80.

Several research analysts have weighed in on the stock. Weiss Ratings downgraded shares of Constellium from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, July 1st. UBS Group lowered their price objective on Constellium from $38.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Wells Fargo & Company lifted their target price on shares of Constellium from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $34.00 price target (up from $30.00) on shares of Constellium in a research note on Thursday, April 30th. Finally, Zacks Research lowered Constellium from a “strong-buy” rating to a “hold” rating in a research note on Monday, June 29th.

Constellium Stock Performance

Shares of CSTM opened at $29.48 on Friday. The company has a market cap of $4.00 billion, a price-to-earnings ratio of 7.60 and a beta of 1.57. The business’s fifty day simple moving average is $31.23 and its two-hundred day simple moving average is $28.76. Constellium has a 12 month low of $13.06 and a 12 month high of $36.99. The company has a current ratio of 1.43, a quick ratio of 0.61 and a debt-to-equity ratio of 1.50.

Constellium (NYSE:CSTM) last posted its earnings results on Wednesday, July 29th. The industrial products company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.18. Constellium had a net margin of 5.69% and a return on equity of 51.66%. The business had revenue of $2.75 billion for the quarter, compared to analysts’ expectations of $2.73 billion. During the same quarter in the prior year, the business earned $0.25 EPS. The business’s revenue for the quarter was up 30.7% compared to the same quarter last year. Research analysts anticipate that Constellium will post 3.7 earnings per share for the current fiscal year.

Insider Activity

In related news, Director John Ormerod sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $35.01, for a total value of $280,080.00. Following the completion of the sale, the director owned 24,873 shares in the company, valued at approximately $870,803.73. The trade was a 24.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Martin Jarrett sold 4,716 shares of the stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $33.46, for a total value of $157,797.36. Following the completion of the transaction, the senior vice president directly owned 15,375 shares in the company, valued at approximately $514,447.50. This trade represents a 23.47% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 50,768 shares of company stock valued at $1,736,880. 1.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership increased its position in shares of Constellium by 620.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company’s stock worth $79,345,000 after purchasing an additional 2,780,260 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Constellium by 894.4% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company’s stock worth $50,545,000 after buying an additional 1,849,554 shares in the last quarter. Millennium Management LLC raised its stake in shares of Constellium by 35.4% during the 3rd quarter. Millennium Management LLC now owns 6,935,766 shares of the industrial products company’s stock worth $103,204,000 after buying an additional 1,813,400 shares in the last quarter. Morgan Stanley lifted its holdings in shares of Constellium by 48.4% in the 4th quarter. Morgan Stanley now owns 3,728,118 shares of the industrial products company’s stock valued at $70,275,000 after buying an additional 1,216,516 shares during the period. Finally, Scopus Asset Management L.P. purchased a new stake in shares of Constellium in the second quarter valued at approximately $14,054,000. Hedge funds and other institutional investors own 92.59% of the company’s stock.

About Constellium

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.